Pharma stocks are set to take off this year, says UBS’ Michael Yee
Michael Yee, global head of biotech research at UBS, joins CNBC's ‘Squawk on the Street' to explain why he is…
Michael Yee, global head of biotech research at UBS, joins CNBC's ‘Squawk on the Street' to explain why he is…
As of the end of its fiscal 2026 first quarter, Microsoft had a contracted backlog of nearly $400 billion. Taiwan…
U.S. defense stocks are surging in Thursday's premarket action after comments by President Donald Trump caused whipsaw trading in the…
President Donald Trump's plans to request an increase in the US military budget are giving a fresh boost to defense…
Older patients should take stock of their prescriptions and make sure they aren't accidentally taking dangerous combinations.
Wells Fargo & Co (NYSE:WFC, XETRA:NWT) analysts expect December's delayed consumer price index (CPI) report to show firmer monthly inflation…
'Mad Money' host Jim Cramer talks how to be selective in the current market.
Retail stocks, a potential winner if the levies are struck down or curtailed, have already run up.
2026 could be a big year for marijuana stocks and even bigger for the industry as a whole. By now,…
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. VRT,…